Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a RAS-activating TMEM87A-RASGRF1 Fusion in an Exceptional Responder to Sunitinib with Non-Small Cell Lung Cancer. | Clin Cancer Res | 2020 | 32312893 | PubTator, text mining | PubMed |
| Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells. | Proc Natl Acad Sci U S A | 2020 | 32312819 | PubTator, text mining | PubMed |
| Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cells. | Sci Rep | 2020 | 32286485 | PubTator, text mining | PubMed |
Decomposition of a set of distributions in extended exponential family form for distinguishing multiple oligo-dimensional marker expression profiles of single-cell populations and visualizing their dynamics. | PLoS One | 2020 | 32275673 | PubTator, text mining | PubMed |
| Granule Cell Dispersion in Human Temporal Lobe Epilepsy: Proteomics Investigation of Neurodevelopmental Migratory Pathways. | Front Cell Neurosci | 2020 | 32256318 | PubTator, text mining | PubMed |
| Platelet-Leukocyte Interplay in Cancer Development and Progression. | Cells | 2020 | 32244723 | PubTator, text mining | PubMed |
| Altered Tregs Differentiation and Impaired Autophagy Correlate to Atherosclerotic Disease. | Front Immunol | 2020 | 32231663 | PubTator, text mining | PubMed |
| Metformin as an Alternative Radiosensitizing Agent to 5-Fluorouracil During Neoadjuvant Treatment for Rectal Cancer. | Dis Colon Rectum | 2020 | 32229782 | PubTator, text mining | PubMed |
| Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts. | Clin Cancer Res | 2020 | 32220884 | PubTator, text mining | PubMed |
| Glutathione Restricts Serine Metabolism to Preserve Regulatory T Cell Function. | Cell Metab | 2020 | 32213345 | PubTator, text mining | PubMed |
| Increased mTOR activation in idiopathic multicentric Castleman disease. | Blood | 2020 | 32206779 | PubTator, text mining | PubMed |
| Insulin-Like Growth Factor Binding Protein-5 in Physiology and Disease. | Front Endocrinol (Lausanne) | 2020 | 32194505 | PubTator, text mining | PubMed |
| Transcriptional suppression of AMPKα1 promotes breast cancer metastasis upon oncogene activation. | Proc Natl Acad Sci U S A | 2020 | 32193335 | PubTator, text mining | PubMed |
| Podocyte-specific deletion of tubular sclerosis complex 2 promotes focal segmental glomerulosclerosis and progressive renal failure. | PLoS One | 2020 | 32191726 | PubTator, text mining | PubMed |
| GTP hydrolysis is modulated by Arg34 in the RASopathy-associated KRASP34R. | Birth Defects Res | 2020 | 32187889 | PubTator, text mining | PubMed |
| The Roles of lncRNA in Cutaneous Squamous Cell Carcinoma. | Front Oncol | 2020 | 32185124 | PubTator, text mining | PubMed |
| A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondrial Metabolism and ER-Resident UFMylation. | Cell | 2020 | 32160526 | PubTator, text mining | PubMed |
| Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition. | Cancers (Basel) | 2020 | 32155915 | PubTator, text mining | PubMed |
| Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer. | Br J Cancer | 2020 | 32147669 | PubTator, text mining | PubMed |
| Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. | Sci Rep | 2020 | 32144278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=47